In my opinion the silence on this matter,from management to shareholders, since the last supplementary prospectus was issued has been deafening.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025